Pliant Therapeutics, Inc. (PLRX)

NASDAQ: PLRX · Real-Time Price · USD

1.110

-0.040 (-3.48%)

At close: Aug 28, 2026, 4:00 PM EDT

1.116

+0.006 (0.54%)

After-hours: Aug 28, 2026, 5:46 PM EDT

Pliant Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	24.88	45.45	71.19	63.23	33.69	51.67
Short-Term Investments	133.22	145.5	284.54	431.01	297.5	148.93
Cash & Short-Term Investments	158.1	190.94	355.72	494.25	331.19	200.6
Cash Growth	-39.86%	-46.32%	-28.03%	49.23%	65.10%	-27.56%
Accounts Receivable	-	-	-	-	1.98	2
Other Receivables	0.87	0.82	2.3	3	1.16	0.47
Receivables	0.87	0.82	2.3	3	3.14	2.47
Prepaid Expenses	2.58	2.79	2.98	4.53	4.85	5.4
Other Current Assets	1.59	1.9	1.26	3.73	1.13	0.98
Total Current Assets	163.14	196.45	362.26	505.5	340.31	209.44
Property, Plant & Equipment	24.7	26.91	32.77	4.78	9.91	10.94
Other Long-Term Assets	2.04	1.87	1.92	1.87	0.39	0.84
Total Assets	189.88	225.23	396.95	512.15	350.61	221.22

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	1.53	0.48	5.96	4.53	1.58	2.97
Accrued Expenses	12.68	14.44	26.72	22.68	19.88	11.99
Current Portion of Leases	2.27	1.45	0.54	1.32	2.46	1.87
Total Current Liabilities	16.48	16.37	33.22	28.52	23.91	16.83
Long-Term Debt	-	-	30.21	10.05	9.93	-
Long-Term Leases	26.47	27.66	29.44	-	3.43	5.33
Total Liabilities	42.96	44.02	92.87	38.58	37.27	22.16

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	1,049	1,041	1,014	972.97	653.71	414.35
Retained Earnings	-901.81	-859.4	-710.05	-499.75	-338.41	-215.09
Comprehensive Income & Other	-0.4	-0.02	0.32	0.35	-1.96	-0.2
Total Common Equity	146.93	181.21	304.08	473.58	313.34	199.06
Shareholders' Equity	146.93	181.21	304.08	473.58	313.34	199.06
Total Liabilities & Equity	189.88	225.23	396.95	512.15	350.61	221.22

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	28.74	29.11	60.19	11.37	15.82	7.19
Net Cash (Debt)	129.36	161.84	295.53	482.87	315.37	193.4
Net Cash Growth	-36.12%	-45.24%	-38.80%	53.11%	63.07%	-30.15%
Net Cash Per Share	2.10	2.64	4.88	8.22	7.51	5.40
Filing Date Shares Outstanding	61.92	61.91	61.24	60.24	58.94	36.11
Total Common Shares Outstanding	61.92	61.45	60.86	59.92	48.94	36.08
Working Capital	146.66	180.08	329.05	476.98	316.4	192.61
Book Value Per Share	2.37	2.95	5.00	7.90	6.40	5.52
Tangible Book Value	146.93	181.21	304.08	473.58	313.34	199.06
Tangible Book Value Per Share	2.37	2.95	5.00	7.90	6.40	5.52
Machinery	10.79	11.5	13.87	10.53	9.61	7.97
Construction In Progress	0.15	0.15	0.35	0.05	0.07	0.04
Leasehold Improvements	2.16	2.16	2.12	1.66	1.65	1.62

SEC Filings: 10-K · 10-Q